Usana Health Sciences Analyst Ratings
Usana Health Sciences Analyst Ratings
While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $62.00 to $53.00. The current price Usana Health Sciences (USNA) is trading at is $45.46, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 16.59% | DA Davidson | $62 → $53 | Maintains | Neutral |
| 04/26/2023 | 23.19% | DA Davidson | $52.5 → $56 | Maintains | Neutral |
| 02/13/2023 | 15.49% | DA Davidson | $49 → $52.5 | Maintains | Neutral |
| 10/27/2022 | 7.79% | DA Davidson | $57 → $49 | Maintains | Neutral |
| 07/28/2022 | 25.38% | DA Davidson | $58 → $57 | Maintains | Neutral |
| 07/12/2022 | 27.58% | DA Davidson | $76 → $58 | Maintains | Neutral |
| 07/07/2022 | 16.59% | Jefferies | $78 → $53 | Downgrades | Hold → Underperform |
| 04/27/2022 | 67.18% | DA Davidson | $86 → $76 | Maintains | Neutral |
| 04/14/2022 | 89.18% | DA Davidson | → $86 | Initiates Coverage On | → Neutral |
| 02/10/2021 | 177.17% | Roth Capital | $107 → $126 | Maintains | Buy |
| 12/17/2020 | 135.37% | Roth Capital | → $107 | Initiates Coverage On | → Buy |
| 08/22/2019 | 42.98% | Jefferies | → $65 | Initiates Coverage On | → Hold |
| 07/03/2019 | 53.98% | Sidoti & Co. | $108 → $70 | Downgrades | Buy → Neutral |
| 04/16/2019 | — | Tigress Financial | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2023 年 10 月 25 日 | 16.59% | DA Davidson | 62 美元 → 53 美元 | 维持 | 中立 |
| 04/26/2023 | 23.19% | DA Davidson | 52.5 美元 → 56 美元 | 维持 | 中立 |
| 02/13/2023 | 15.49% | DA Davidson | 49 美元 → 52.5 美元 | 维持 | 中立 |
| 10/27/2022 | 7.79% | DA Davidson | 57 美元 → 49 美元 | 维持 | 中立 |
| 07/28/2022 | 25.38% | DA Davidson | 58 美元 → 57 美元 | 维持 | 中立 |
| 2022 年 12 月 7 日 | 27.58% | DA Davidson | 76 美元 → 58 美元 | 维持 | 中立 |
| 07/07/2022 | 16.59% | 杰富瑞 | 78 美元 → 53 美元 | 降级 | 持有 → 表现不佳 |
| 04/27/2022 | 67.18% | DA Davidson | 86 美元 → 76 美元 | 维持 | 中立 |
| 2022 年 4 月 14 日 | 89.18% | DA Davidson | → 86 美元 | 启动覆盖范围开启 | → 中立 |
| 2021 年 10 月 2 日 | 177.17% | 罗斯资本 | 107 美元 → 126 美元 | 维持 | 购买 |
| 2020 年 12 月 17 日 | 135.37% | 罗斯资本 | → 107 美元 | 启动覆盖范围开启 | → 购买 |
| 08/22/2019 | 42.98% | 杰富瑞 | → 65 美元 | 启动覆盖范围开启 | → 按住 |
| 07/03/2019 | 53.98% | Sidoti & Co. | 108 美元 → 70 美元 | 降级 | 买入 → 中性 |
| 04/16/2019 | — | 泰格雷斯金融 | 启动覆盖范围开启 | → 购买 |
What is the target price for Usana Health Sciences (USNA)?
Usana Health Sciences（USNA）的目标价格是多少？
The latest price target for Usana Health Sciences (NYSE: USNA) was reported by DA Davidson on October 25, 2023. The analyst firm set a price target for $53.00 expecting USNA to rise to within 12 months (a possible 16.59% upside). 4 analyst firms have reported ratings in the last year.
达·戴维森于2023年10月25日公布了Usana Health Sciences（纽约证券交易所代码：USNA）的最新目标股价。该分析公司将目标股价设定为53.00美元，预计USNA将在12个月内上涨至59％（可能上涨16.59％）。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Usana Health Sciences (USNA)?
Usana Health Sciences（USNA）的最新分析师评级是多少？
The latest analyst rating for Usana Health Sciences (NYSE: USNA) was provided by DA Davidson, and Usana Health Sciences maintained their neutral rating.
Usana Health Sciences（纽约证券交易所代码：USNA）的最新分析师评级由戴维森提供，Usana Health Sciences维持中性评级。
When is the next analyst rating going to be posted or updated for Usana Health Sciences (USNA)?
Usana Health Sciences（USNA）的下一个分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Usana Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Usana Health Sciences was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Usana Health Sciences的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。Usana Health Sciences的最后一次评级是在2023年10月25日提交的，因此您应该预计下一个评级将在2024年10月25日左右公布。
Is the Analyst Rating Usana Health Sciences (USNA) correct?
分析师评级Usana Health Sciences（USNA）是否正确？
While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $62.00 to $53.00. The current price Usana Health Sciences (USNA) is trading at is $45.46, which is out of the analyst's predicted range.
尽管评级是主观的，并将发生变化，但最新的Usana健康科学（USNA）评级维持不变，目标股价为62.00美元至53.00美元。Usana Health Sciences（USNA）目前的交易价格为45.46美元，超出了分析师的预测区间。
